Syngenta expects ChemChina takeover will be approved by U.S. regulators by year end

Screen Shot at PM

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

Syngenta AG, which has agreed to be taken over by China National Chemical Corp. for $43 billion, said talks with regulatory authorities to win approval for the deal have been constructive and the Swiss company is confident the transaction can be closed on time.

Talks with the Committee on Foreign Investment in the U.S. [CFIUS] are ongoing and the goal remains to complete the deal by year end, Chief Executive Officer Erik Fyrwald said in a phone interview on [July 22]. . . .

. . . .

ChemChina is seeking regulatory approval for the purchase that will make it the worldโ€™s largest supplier of pesticides and other crop-care chemicals, albeit temporarily. Dow Chemical Co.โ€™s merger with DuPont Co. and Bayer AGโ€™s possible purchase of Monsanto Co. will reorder the rankings as the top six suppliers jostle for market share and financial power. . .

With Syngenta, investors are focused on the process of winning approval from CFIUS in a presidential election year. The regulator can recommend a deal be blocked for reasons of national security, and this time around the panel includes the USDAย as the planned acquisition involves food security. . . .

Read full, original post:ย Syngenta Says U.S. Talks Over ChemChina Bid โ€˜Constructiveโ€™

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosateโ€”the world's most heavily-used herbicideโ€”pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot 2025-08-25 203032
Mazzengaโ€™s 20-year old muscles: How a still-going-strong 92-year old sprinter wins every race she enters
Screenshot-2026-06-08-at-10.19.30-AM
โ€˜Naturalโ€™ wellness supplements linked to liver injury
Screenshot-2026-06-05-at-2.12.30-PM
Some plants can poison you. So how did humans figure out what is safe to eat?
ChatGPT-Image-May-28-2026-12_56_54-PM
Viewpoint: Vaccines' non-specific effects? The โ€˜shoddyโ€™ Danish couple whose 'researchโ€™ inspires RFK, Jr.โ€™s health delusion
Screen Shot at AM
Facts & Fallacies Podcast: Right-wing politics bad for your health? Separating speculation from science
Credit: ACSH
Viewpoint: Who and whatโ€™s to blame for the surge in vaccine-preventable diseases?
Screenshot-2026-06-05-at-1.44.09-PM
Viewpoint: Scientists have scrapped the worst-case climate scenario. Is that proof that climate change is a hoax, as Trump claims?
ChatGPT-Image-Jun-9-2026-03_24_05-PM
Misinformed parents overdosing children with Vitamin A to fight measles
Screenshot 2025-07-30 at 10.48
Can gene editing eliminate Down syndrome? Scientists have done it in lab-grown cells
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpointโ€”โ€œMiracle moleculeโ€ debunked: Why acemannan supplements donโ€™t work
ChatGPT-Image-Jun-9-2026-11_54_59-AM
Why weight-loss drugs might be reducing cancer rates and making treatment more effective
ChatGPT-Image-Jun-9-2026-12_30_14-PM
The โ€˜low-qualityโ€™, retracted studies RFK, Jr. and MAHA rely on for anti-vaccine claims
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.